PRR.ASX

Immutep Limited

Recent research View all research

About Immutep Limited

Prima BioMed Ltd (PRR) is a global biotechnology company headquartered in Australia. PRR focuses on personalised bio-therapeutic products for cancer. Its lead product is CVac, an autologous dendritic cell-based product currently in clinical trials for ovarian cancer patients who are in remission. PRR also develops an oral vaccine against Human Papilloma Virus (HPV).

Forsyth Barr Analyst

Share price performance

All stock prices and news delayed 20 minutes

05:58 March 19th 2019 NZDT

0.03 -2.9%

0.03 Buy

0.03 Sell

Last 0.03

Open 0.03

High 0.03

Low 0.03

Volume 165,884

Turnover $5,491

Most recent trades All trades for the day

Time Price Volume Value

Latest Immutep Limited research

Today's trades

Trade Number Time Price Volume Value

Latest Immutep Limited news

There is currently no news available.

If you're new to investing or just have a question please call us: 0800 367 227